688780005	688780005	CD	B-NP	O
|	|	NNP	I-NP	O
VH	VH	NNP	I-NP	O
|	|	VBD	B-VP	O
59941699	59941699	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5920473	5920473	CD	B-NP	O
|	|	CC	I-NP	O
3/9/2006	3/9/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CAD	CAD	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/14/2006	4/14/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/18/2006	6/18/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
PREHN	PREHN	NN	B-NP	O
,	,	,	O	O
DAMION	DAMION	NN	B-NP	O
045-69-78-8	045-69-78-8	CD	I-NP	O
A	A	NNP	I-NP	O
S	S	NNP	I-NP	O
Sadenabirm	Sadenabirm	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
6/17/06	6/17/06	CD	B-NP	O
AT	AT	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MOREDOCK	MOREDOCK	NNP	B-NP	O
,	,	,	O	O
ROLAND	ROLAND	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ATENOLOL	ATENOLOL	NN	B-NP	O
125	125	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
6/16	6/16	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
LIPITOR	LIPITOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
p/w	p/w	NN	B-NP	O
angina	angina	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
PCI	PCI	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/23/06	9/23/06	CD	B-NP	O
by	by	IN	B-PP	O
KOTH	KOTH	NNP	B-NP	O
,	,	,	O	O
JEFFERSON	JEFFERSON	NNP	B-NP	O
KEVIN	KEVIN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
MICONAZOLE	MICONAZOLE	NNP	B-NP	O
NITRATE	NITRATE	NNP	I-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
MICONAZOLE	MICONAZOLE	NNP	B-NP	O
NITRATE	NITRATE	NNP	I-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
CALCIUM	CALCIUM	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
KEFLEX	KEFLEX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CEPHALEXIN	CEPHALEXIN	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
500	500	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QID	QID	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
6/16	6/16	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
started	start	VBD	B-VP	O
1/10	1/10	CD	B-NP	O
,	,	,	O	O
stop	stop	VB	B-VP	O
8/22	8/22	CD	B-NP	O
PLAVIX	PLAVIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Tomorrow	Tomorrow	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
10/7	10/7	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
ASA	ASA	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
7/3	7/3	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
REL	REL	NNP	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NNP	B-NP	O
KCL	KCL	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
CGH	CGH	NN	B-NP	O
Potassium	Potassium	NN	I-NP	O
Chloride	Chloride	NN	I-NP	O
Policy	Policy	NN	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	JJ	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/17/06	6/17/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
LISINOPRIL	LISINOPRIL	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
1/29/06	1/29/06	CD	B-NP	O
by	by	IN	B-PP	O
RAMSIER	RAMSIER	NN	B-NP	O
,	,	,	O	O
TRENTON	TRENTON	NNP	B-NP	O
H.	H.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IMMED	IMMED	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O

PO	PO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
197178673	197178673	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/9/06	3/9/06	CD	B-NP	O
by	by	IN	B-PP	O
BI	BI	NNP	B-NP	O
,	,	,	O	O
GLENN	GLENN	NNP	B-NP	O
N.	N.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitering	monitere	VBG	B-VP	O
MICONAZOLE	MICONAZOLE	NN	B-NP	O
NITRATE	NITRATE	NN	I-NP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
CREAM	CREAM	NN	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
apply	apply	VB	B-VP	O
in	in	IN	B-PP	O
between	between	IN	B-PP	O
toes	toe	NNS	B-NP	O
B/L	B/L	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/23/06	9/23/06	CD	B-NP	O
by	by	IN	B-PP	O
HESBY	HESBY	NNP	B-NP	O
,	,	,	O	O
NICOLAS	NICOLAS	NNP	B-NP	O
DOMINICK	DOMINICK	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LIPITOR	LIPITOR	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
149201174	149201174	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
MICONAZOLE	MICONAZOLE	NNP	B-NP	O
NITRATE	NITRATE	NNP	I-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/9/06	3/9/06	CD	B-NP	O
by	by	IN	B-PP	O
POCAI	POCAI	NNP	B-NP	O
,	,	,	O	O
GARY	GARY	NNP	B-NP	O
F.	F.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

SERIOUS	SERIOUS	JJ	B-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
MICONAZOLE	MICONAZOLE	NNP	I-NP	O
NITRATE	NITRATE	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
MICONAZOLE	MICONAZOLE	NNP	I-NP	O
NITRATE	NITRATE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
MICONAZOLE	MICONAZOLE	NN	I-NP	O
NITRATE	NITRATE	NN	I-NP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
POWDER	POWDER	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
apply	apply	VB	B-VP	O
to	to	TO	I-VP	O
groin	groin	VB	I-VP	O
Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/23/06	9/23/06	CD	B-NP	O
by	by	IN	B-PP	O
MUEHL	MUEHL	NNP	B-NP	O
,	,	,	O	O
REID	REID	NNP	B-NP	B-DNA
GENE	GENE	NNP	I-NP	I-DNA
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LIPITOR	LIPITOR	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
149201174	149201174	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
MICONAZOLE	MICONAZOLE	NNP	B-NP	O
NITRATE	NITRATE	NNP	I-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
NIASPAN	NIASPAN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NICOTINIC	NICOTINIC	NNP	I-NP	O
ACID	ACID	NNP	I-NP	O
SUSTAINED	SUSTAINED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
0.5	0.5	CD	I-NP	O
GM	GM	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Take	Take	VB	B-VP	O
aspirin	aspirin	NN	B-NP	O
30	30	CD	B-NP	O
minutes	minute	NNS	I-NP	O
before	before	RB	O	O
-	-	HYPH	O	O
hand	hand	NN	B-NP	O
to	to	TO	B-VP	O
prevent	prevent	VB	I-VP	O
facial	facial	JJ	B-NP	O
flushing	flushing	NN	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/23/06	9/23/06	CD	B-NP	O
by	by	IN	B-PP	O
HARTZFELD	HARTZFELD	NN	B-NP	O
,	,	,	O	O
NICK	NICK	NNP	B-NP	O
TIMMY	TIMMY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LIPITOR	LIPITOR	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
149201174	149201174	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
CALCIUM	CALCIUM	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/9/06	3/9/06	CD	B-NP	O
by	by	IN	B-PP	O
RAUHE	RAUHE	NN	B-NP	B-protein
,	,	,	O	O
WESTON	WESTON	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Weakland	Weakland	NNP	I-NP	O
,	,	,	O	O
Primary	Primary	NNP	B-NP	O
Care	Care	NNP	I-NP	O
1-2	1-2	NN	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
call	call	VB	I-VP	O
the	the	DT	B-NP	O
office	office	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
hear	hear	VB	I-VP	O
from	from	IN	B-PP	O
them	them	PRP	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
2	2	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Trouser	Trouser	NNP	I-NP	O
,	,	,	O	O
Cardiology	Cardiology	NNP	B-NP	O
409-240-1358	409-240-1358	CD	I-NP	O
Please	Please	NNP	I-NP	O
call	call	NN	I-NP	O
in	in	IN	B-PP	O
1-2	1-2	CD	B-NP	O
days	day	NNS	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
hear	hear	VB	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
office	office	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
must	must	MD	B-VP	O
be	be	VB	I-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
2-4	2-4	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Shellfish	Shellfish	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
angina	angina	NN	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CAD	CAD	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NN	B-NP	O
2	2	CD	I-NP	O
VESSEL	VESSEL	NN	I-NP	O
CAD	CAD	NN	I-NP	O
HTN	HTN	NN	I-NP	O
+	+	SYM	B-VP	O
ETT	ETT	NN	B-NP	B-protein
4/22	4/22	CD	I-NP	I-protein
W	W	NN	I-NP	I-protein
/	/	SYM	B-NP	O
ST	ST	NN	I-NP	O
DEPRESSION	DEPRESSION	NN	I-NP	O
ANGINA	ANGINA	NN	I-NP	O
,	,	,	O	O
?	?	.	O	O

UNSTABLE	UNSTABLE	NN	B-NP	O
CURRENTLY	CURRENTLY	NN	I-NP	O
STABLE	STABLE	NN	I-NP	O
NO	NO	NN	I-NP	O
CHEST	CHEST	NN	I-NP	O
PAIN	PAIN	NN	I-NP	O
SINCE	SINCE	NN	I-NP	O
10/9	10/9	CD	I-NP	O
S/P	S/P	NN	I-NP	O
CATH	CATH	NN	I-NP	O
6/9	6/9	CD	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
cardiac	cardiac	JJ	I-NP	O
cath	cath	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
cc	cc	NN	B-NP	O
:	:	:	O	O
SOB/DOE	SOB/DOE	NNP	B-NP	O
x	x	CC	O	O
9	9	CD	B-NP	O
months	month	NNS	I-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
60M	60M	NN	B-NP	O
HTN	HTN	NN	I-NP	O
,	,	,	O	O
obese	obese	NN	B-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	O
S/P	S/P	NN	I-NP	O
stent	stent	NN	I-NP	O
in	in	IN	B-PP	O
'96	'96	CD	B-NP	O
to	to	TO	B-PP	O
LCx	LCx	NN	B-NP	B-protein
,	,	,	O	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
DOE	DOE	NN	I-NP	O
and	and	CC	O	O
substernal	substernal	JJ	B-NP	O
chest	chest	NN	I-NP	O
tightness	tightness	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
walking	walk	VBG	B-VP	O
approx	approx	NN	B-NP	O
200	200	CD	B-NP	O
yards	yard	NNS	I-NP	O
.	.	.	O	O

Sx	Sx	NN	B-NP	O
resolve	resolve	VBP	B-VP	O
with	with	IN	B-PP	O
rest	rest	NN	B-NP	O
.	.	.	O	O

Associated	Associate	VBN	B-VP	O
with	with	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
and	and	CC	O	O
periodic	periodic	JJ	B-NP	O
radiation	radiation	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
R	R	NN	I-NP	O
chest	chest	NN	I-NP	O
.	.	.	O	O

Have	Have	VB	B-VP	O
been	be	VBN	I-VP	O
slowly	slowly	RB	I-VP	O
progressing	progress	VBG	I-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

Since	Since	IN	B-PP	O
last	last	JJ	B-NP	O
cath	cath	NN	I-NP	O
in	in	IN	B-PP	O
'96	'96	CD	B-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
few	few	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
releived	releive	VBN	B-VP	O
with	with	IN	B-PP	O
sl	sl	NN	B-NP	O
nitro	nitro	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
ROS	ROS	NN	B-NP	O
positive	positive	JJ	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
3	3	CD	I-NP	O
pillows	pillow	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
PND	PND	NN	I-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
lightheadedness	lightheadedness	NN	I-NP	O
,	,	,	O	O
dizziness	dizziness	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
emesis	emesis	NN	B-NP	O
,	,	,	O	O
cough	cough	NN	B-NP	O
,	,	,	O	O
abd	abd	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
fever	fever	NN	I-NP	O
or	or	CC	I-NP	O
chills	chill	NNS	I-NP	O
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
gain	gain	NN	I-NP	O
of	of	IN	B-PP	O
100	100	CD	B-NP	O
lb	lb	NN	I-NP	O
in	in	IN	B-PP	O
setting	setting	NN	B-NP	O
of	of	IN	B-PP	O
family	family	NN	B-NP	O
illnesses	illness	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
got	get	VBD	B-VP	O
PECT	PECT	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
neg	neg	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Stress	Stress	NNP	B-NP	O
Echo	Echo	NNP	I-NP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
ischimia	ischimia	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
submax	submax	NN	I-NP	O
HR	HR	NN	I-NP	O
,	,	,	O	O
+	+	SYM	B-NP	O
MIBI	MIBI	NNP	B-NP	O
.	.	.	O	O

Admitted	Admit	VBN	B-VP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NN	B-NP	O
:	:	:	O	O
T98	T98	NN	B-NP	O
.6	.6	CD	I-NP	O
P70	P70	NN	I-NP	O
BP141/69	BP141/69	NN	I-NP	O
Sat	Sat	NN	I-NP	O
94	94	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
ASA	ASA	NNP	B-NP	O
and	and	CC	O	O
Keflex	Keflex	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
for	for	IN	B-PP	O
LE	LE	NNP	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

********	********	SYM	O	O
*	*	SYM	B-NP	O
PMHx	PMHx	NN	I-NP	O
:	:	:	O	O
CAD	CAD	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
2	2	CD	B-NP	O
stents	stent	NNS	I-NP	O
to	to	TO	B-PP	O
LCx	LCx	NN	B-NP	B-protein
'96	'96	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
hepatitis	hepatitis	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
resolved	resolve	VBD	B-VP	O
-RRB-	-RRB-	JJ	B-NP	O
,	,	,	I-NP	O
colonic	colonic	JJ	I-NP	O
polyps	polyp	NNS	I-NP	O
,	,	,	O	O
osteoarthritis	osteoarthritis	NN	B-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
appy	appy	JJ	B-ADJP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
R	R	NN	I-NP	O
THR	THR	NN	I-NP	O
*	*	SYM	B-NP	O
ALL	ALL	NN	I-NP	O
:	:	:	O	O
Shellfish	Shellfish	NN	B-NP	O
--	--	:	O	O
>	>	SYM	B-NP	O
Rash	Rash	NN	I-NP	O
*	*	SYM	B-NP	O
Home	Home	NNP	I-NP	O
Meds	Med	NNPS	I-NP	O
:	:	:	O	O
norvasc	norvasc	NN	B-NP	O
10mg	10mg	CD	I-NP	O
,	,	,	O	O
lasix	lasix	CD	B-NP	O
40mg	40mg	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
lipitor	lipitor	NN	B-NP	O
80mg	80mg	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
100mg	100mg	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
isordil	isordil	NN	B-NP	O
20mg	20mg	NN	I-NP	O
tid	tid	NN	I-NP	O
,	,	,	O	O
ASA	ASA	NN	B-NP	O
325mg	325mg	NN	I-NP	O
qd	qd	NN	I-NP	O
*	*	SYM	O	O
Social	Social	NNP	B-NP	O
Hx	Hx	NNP	I-NP	O
:	:	:	O	O
married	marry	VBN	B-VP	O
,	,	,	O	O
wife	wife	NN	B-NP	O
in	in	IN	B-PP	O
EMC	EMC	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	O	O
Alzheimer	Alzheimer	NN	B-NP	O
's	's	POS	B-NP	O
.	.	.	O	O

Lives	Life	NNS	B-NP	O
alone	alone	RB	B-ADVP	O
.	.	.	O	O

Mother	Mother	NNP	B-NP	O
died	die	VBD	B-VP	O
a	a	DT	B-NP	O
year	year	NN	I-NP	O
ago	ago	RB	B-ADVP	O
from	from	IN	B-PP	O
malignancy	malignancy	NN	B-NP	O
,	,	,	O	O
used	use	VBN	B-VP	O
to	to	TO	B-VP	O
take	take	VB	I-VP	O
care	care	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP	B-NP	O
.	.	.	O	O

Past	Past	NN	B-NP	O
tobacco	tobacco	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
40pk	40pk	CD	I-NP	O
yrs	yr	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
ETOH	ETOH	NN	I-NP	B-protein
or	or	CC	I-NP	O
drugs	drug	NNS	I-NP	O
*	*	SYM	O	O
Fam	Fam	NNP	B-NP	O
Hx	Hx	NNP	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
CAD	CAD	NN	I-NP	B-protein
*********	*********	SYM	B-NP	I-protein
**	**	NN	I-NP	I-protein
Stress	Stress	NNP	I-NP	O
Echo	Echo	NNP	I-NP	O
2/3	2/3	CD	I-NP	O
EF	EF	NN	I-NP	O
45	45	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
borderline	borderline	JJ	B-NP	O
LVE	LVE	NN	I-NP	O
,	,	,	O	O
concentric	concentric	JJ	B-NP	O
LVH	LVH	NN	I-NP	O
,	,	,	O	O
post	post	VBP	B-VP	O
basilar	basilar	JJ	B-NP	B-protein
HK	HK	NN	I-NP	I-protein
and	and	CC	O	O
mid-inf	mid-inf	JJ	B-NP	O
HK	HK	NN	I-NP	O
.	.	.	O	O

LAE	LAE	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
ischimia	ischimia	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
submax	submax	NN	B-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
peak	peak	JJ	I-NP	O
HR	HR	NN	I-NP	O
85bmp	85bmp	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
**	**	SYM	B-NP	O
MIVI	MIVI	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
2/22/06	2/22/06	CD	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
:	:	:	O	O
non-ischimic	non-ischimic	JJ	B-ADJP	O
.	.	.	O	O

Patchy	Patchy	JJ	B-NP	O
uptake	uptake	NN	I-NP	O
diffusely	diffusely	RB	B-ADJP	O
w	w	JJ	I-ADJP	O
/	/	SYM	O	O
small	small	JJ	B-NP	O
reversible	reversible	JJ	I-NP	O
apical	apical	JJ	I-NP	O
defect	defect	NN	I-NP	O
-	-	HYPH	O	O
>	>	SYM	B-NP	O
?	?	.	O	O

mild	mild	JJ	B-NP	O
ischimia	ischimia	NN	I-NP	O
in	in	IN	B-PP	O
LAD	LAD	NN	B-NP	O
territory	territory	NN	I-NP	O
.	.	.	O	O

Small	Small	JJ	B-NP	O
defect	defect	NN	I-NP	O
of	of	IN	B-PP	O
medium	medium	NN	B-NP	O
intensity	intensity	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
basal	basal	JJ	I-NP	O
inferolateral	inferolateral	JJ	I-NP	O
wall	wall	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
fixed	fix	VBN	I-VP	O
c/w	c/w	NN	B-NP	O
LCx/OM	LCx/OM	NN	I-NP	O
scar	scar	NN	I-NP	O
.	.	.	O	O

**	**	SYM	O	O
PECT	PECT	NN	B-NP	B-protein
2/3	2/3	CD	I-NP	I-protein
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
PE	PE	NN	B-NP	B-protein
**	**	SYM	B-NP	I-protein
CXR	CXR	NN	I-NP	I-protein
-LRB-	-LRB-	SYM	B-NP	O
admission	admission	NN	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
:	:	:	O	O
R	R	NN	B-NP	O
hilar	hilar	JJ	I-NP	O
opacity	opacity	NN	I-NP	O
.	.	.	O	O

**	**	SYM	B-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
SR	SR	NN	B-NP	O
75bmp	75bmp	NN	I-NP	O
,	,	,	O	O
RBBB	RBBB	NN	B-NP	B-protein
,	,	,	O	O
LEA	LEA	NN	B-NP	B-protein
,	,	,	O	O
PVC	PVC	NN	B-NP	B-protein
,	,	,	O	O
strain	strain	NN	B-NP	O
pattern	pattern	NN	I-NP	O
Cath	Cath	NN	I-NP	O
10/23/06	10/23/06	CD	I-NP	O
:	:	:	O	O
Right	Right	NNP	B-NP	O
Dominant	Dominant	NNP	I-NP	O
,	,	,	O	O
LAD	LAD	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Proximal	Proximal	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Discrete	Discrete	NNP	B-NP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
LCX	LCX	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Mid	Mid	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Discrete	Discrete	NNP	B-NP	O
80	80	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
RCA	RCA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Proximal	Proximal	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Discrete	Discrete	NNP	B-NP	O
99	99	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
RT	RT	NN	B-NP	B-protein
LV-BR	LV-BR	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	O
Ostial	Ostial	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Discrete	Discrete	NNP	B-NP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
RT	RT	NN	B-NP	B-protein
PDA	PDA	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	O
Proximal	Proximal	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Discrete	Discrete	NNP	B-NP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
Collateral	Collateral	JJ	B-NP	O
flow	flow	NN	I-NP	O
from	from	IN	B-PP	O
LAD	LAD	NN	B-NP	B-protein
to	to	TO	B-PP	O
RT	RT	NN	B-NP	B-protein
PDA	PDA	NN	I-NP	I-protein
,	,	,	O	O
Collateral	Collateral	JJ	B-NP	O
flow	flow	NN	I-NP	O
from	from	IN	B-PP	O
CX	CX	NN	B-NP	B-protein
to	to	TO	B-PP	O
RT	RT	NN	B-NP	O
LV-BR	LV-BR	NN	I-NP	O
Right	Right	NN	I-NP	O
heart	heart	NN	I-NP	O
Cath	Cath	NN	I-NP	O
10/23/06	10/23/06	CD	I-NP	O
:	:	:	O	O
RA	RA	NN	B-NP	O
13/13	13/13	CD	B-NP	O
RV	RV	NN	I-NP	O
41	41	CD	B-NP	O
/	/	SYM	I-NP	O
-1	-1	NN	I-NP	O
,	,	,	O	O
PA	PA	NNP	B-NP	O
47/16	47/16	CD	I-NP	O
,	,	,	O	O
PW	PW	NNP	B-NP	O
27/25	27/25	CD	I-NP	O
PA	PA	NNP	I-NP	O
:	:	:	O	O
74	74	CD	B-NP	O
%	%	NN	I-NP	O
Fick	Fick	NN	I-NP	O
CO	CO	NN	I-NP	O
:	:	:	O	O
6.95	6.95	CD	B-NP	O
Thermal	Thermal	JJ	I-NP	O
CO	CO	NN	I-NP	O
:	:	:	O	O
SVR	SVR	NN	B-NP	O
:	:	:	O	O
1163	1163	CD	B-NP	O
Fick	Fick	NNP	I-NP	O
CI	CI	NNP	I-NP	O
:	:	:	O	O
2.76	2.76	CD	B-NP	O
Thermal	Thermal	JJ	I-NP	O
CI	CI	NN	I-NP	O
:	:	:	O	O
PVR	PVR	NN	B-NP	B-protein
:	:	:	O	O
69	69	CD	B-NP	O
Cath	Cath	NNP	I-NP	O
4/3/06	4/3/06	CD	I-NP	O
:	:	:	O	O
PCI	PCI	NN	B-NP	O
and	and	CC	I-NP	O
stent	stent	NN	I-NP	O
to	to	TO	B-PP	O
LCx	LCx	NN	B-NP	B-protein
.	.	.	O	O

**********	**********	SYM	O	O
*	*	SYM	O	O
Daily	Daily	NNP	B-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
T98	T98	NN	B-NP	O
.3	.3	NN	I-NP	O
P94	P94	NN	I-NP	O
BP130/80	BP130/80	NN	I-NP	O
Sat	Sat	NN	I-NP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
GEN	GEN	NN	I-NP	O
:	:	:	O	O
NAD	NAD	NN	B-NP	O
,	,	,	O	O
A	A	NNP	B-NP	O
&	&	CC	I-NP	O
O	O	NNP	I-NP	O
x3	x3	CD	I-NP	O
HEENT	HEENT	NNP	I-NP	O
:	:	:	O	O
mmm	mmm	NN	B-NP	O
,	,	,	O	O
PERRLA	PERRLA	NN	B-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	O
8cm	8cm	NN	I-NP	O
,	,	,	O	O
CEA	CEA	NN	B-NP	O
scars	scar	NNS	I-NP	O
b/l	b/l	NN	I-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
1/6	1/6	CD	B-NP	O
RUSB	RUSB	NN	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
;	;	:	O	O
non-displaced	non-displaced	JJ	B-NP	O
PMI	PMI	NN	I-NP	O
,	,	,	O	O
B/L	B/L	NN	B-NP	B-protein
CEA	CEA	NN	I-NP	I-protein
scars	scar	NNS	I-NP	I-protein
,	,	,	O	O
no	no	DT	B-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

ABD	ABD	NN	B-NP	O
:	:	:	O	O
obese	obese	JJ	B-NP	O
,	,	,	I-NP	O
NABS	NABS	NNP	I-NP	O
,	,	,	I-NP	O
nt	nt	NN	I-NP	O
,	,	,	O	O
nd	nd	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
HSM	HSM	NN	I-NP	B-protein
,	,	,	O	O
B/L	B/L	NN	B-NP	O
femoral	femoral	JJ	I-NP	O
bruits	bruit	NNS	I-NP	O
PULM	PULM	NN	I-NP	O
:	:	:	O	O
CTA	CTA	NN	B-NP	O
b/l	b/l	NN	I-NP	O
EXTR	EXTR	NN	I-NP	O
:	:	:	O	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
b/l	b/l	NN	I-NP	O
edema	edema	NN	I-NP	O
to	to	TO	B-PP	O
knees	knee	NNS	B-NP	O
,	,	,	O	O
b/l	b/l	NN	B-NP	O
ankle	ankle	NN	I-NP	O
erythema	erythema	NN	I-NP	O
and	and	CC	O	O
warmth	warmth	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
exudation	exudation	NN	B-NP	O
on	on	IN	B-PP	O
L	L	NN	B-NP	O
,	,	,	O	O
+	+	CC	O	O
onchomycosis	onchomycosis	NN	B-NP	O
B/L	B/L	NN	I-NP	O
.	.	.	O	O

NEURO	NEURO	NN	B-NP	B-protein
:	:	:	O	O
full	full	JJ	B-NP	O
strength	strength	NN	I-NP	O
&	&	CC	I-NP	O
sensation	sensation	NN	I-NP	O
.	.	.	O	O

Limited	Limit	VBN	B-NP	O
R	R	NN	I-NP	O
eye	eye	NN	I-NP	O
abduction	abduction	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
Lateral	Lateral	JJ	I-NP	O
Rectus	Rectus	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
.	.	.	O	O

PERRLA	PERRLA	NN	B-NP	O
.	.	.	O	O

***********	***********	SYM	B-NP	O
A/P	A/P	NN	I-NP	O
:	:	:	O	O
60	60	CD	B-NP	O
yo	yo	NN	I-NP	O
M	M	NN	I-NP	O
with	with	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	I-NP	O
HTN	HTN	NN	I-NP	B-protein
and	and	CC	I-NP	O
Hyperlipidemia	Hyperlipidemia	NN	I-NP	O
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
increasing	increase	VBG	B-VP	O
DOE	DOE	NNP	B-NP	O
and	and	CC	O	O
intermidiate	intermidiate	VB	B-VP	O
MIBI	MIBI	NNP	B-NP	O
as	as	IN	B-PP	O
out-pt	out-pt	JJ	B-ADJP	O
in	in	IN	B-PP	O
setting	set	VBG	B-VP	O
of	of	IN	B-PP	O
significant	significant	JJ	B-NP	O
deconditioning	deconditioning	NN	I-NP	O
and	and	CC	O	O
multiple	multiple	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
risk	risk	NN	I-NP	O
factors	factor	NNS	I-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
i	i	AFX	B-NP	O
-	-	HYPH	I-NP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
active	active	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

Admission	Admission	NN	B-NP	O
cardiac	cardiac	JJ	I-NP	O
markers	marker	NNS	I-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Continued	Continue	VBN	B-NP	O
statin/high	statin/high	JJ	I-NP	B-protein
dose	dose	NN	I-NP	I-protein
ASA	ASA	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
post	post	NN	I-NP	I-protein
stent	stent	JJ	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
/	/	SYM	B-NP	O
started	start	VBD	B-VP	O
Plavix	Plavix	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
post	post	VBD	B-VP	O
stent	stent	JJ	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
/	/	SYM	B-VP	O
increased	increase	VBN	B-NP	O
atenolol	atenolol	NN	I-NP	O
from	from	IN	B-PP	O
100mg	100mg	CD	B-NP	O
to	to	TO	I-NP	O
125	125	CD	I-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

Started	Started	NNP	B-NP	O
Niaspan	Niaspan	NNP	I-NP	O
for	for	IN	B-PP	O
low	low	JJ	B-NP	O
HDL	HDL	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Trig	Trig	NNP	I-NP	O
138	138	CD	I-NP	O
,	,	,	O	O
HDL	HDL	NN	B-NP	B-DNA
38	38	CD	I-NP	I-DNA
,	,	,	O	O
LDL	LDL	NN	B-NP	B-protein
85	85	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Subtotal	Subtotal	JJ	B-NP	O
RCA	RCA	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
,	,	,	O	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
OM	OM	NN	I-NP	O
,	,	,	O	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
mid	mid	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
.	.	.	O	O

Cypher	Cypher	NNP	B-NP	O
Stents	Stent	NNS	I-NP	O
in	in	IN	B-PP	O
mid	mid	JJ	B-NP	O
RCA	RCA	NN	I-NP	O
to	to	TO	B-PP	O
os	o	NNS	B-NP	O
.	.	.	O	O

Returned	Return	VBN	B-VP	O
to	to	TO	B-PP	O
cath	cath	NN	B-NP	B-protein
lab	lab	NN	I-NP	I-protein
for	for	IN	B-PP	O
Lcx	Lcx	NN	B-NP	B-protein
PCI	PCI	NN	I-NP	O
6/26	6/26	CD	I-NP	O
and	and	CC	I-NP	O
cypher	cypher	NN	I-NP	O
stent	stent	NN	I-NP	O
placed	place	VBN	B-VP	O
.	.	.	O	O

Wedge	Wedge	NNP	B-NP	O
elevated	elevate	VBD	B-VP	O
.	.	.	O	O

EF	EF	NN	B-NP	O
45	45	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
stress	stress	NN	B-NP	O
echo	echo	NN	I-NP	O
.	.	.	O	O

Difficult	Difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
volume	volume	NN	B-NP	O
status	status	NN	I-NP	O
by	by	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
exam	exam	NN	I-NP	O
alone	alone	RB	B-ADVP	O
.	.	.	O	O

Increased	Increase	VBN	B-NP	O
lasix	lasix	CD	I-NP	O
from	from	IN	I-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
daily	daily	RB	B-ADVP	O
to	to	TO	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
,	,	,	O	O
increased	increase	VBN	B-NP	O
b-blocker	b-blocker	NN	I-NP	O
,	,	,	O	O
continued	continue	VBD	B-VP	O
norvasc	norvasc	NN	B-NP	O
and	and	CC	O	O
stopped	stop	VBD	B-VP	O
isordil	isordil	NN	B-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
stop	stop	VB	I-VP	O
norvasc	norvasc	NN	B-NP	O
to	to	TO	B-VP	O
allow	allow	VB	I-VP	O
room	room	NN	B-NP	O
for	for	IN	B-PP	O
ACE-I	ACE-I	NN	B-NP	O
titration	titration	NN	I-NP	O
.	.	.	O	O

r-telemetry	r-telemetry	JJ	B-NP	O
monitoring	monitoring	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
2	2	CD	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
NSVT	NSVT	NN	B-NP	B-protein
post-PCI	post-PCI	NN	I-NP	I-protein
.	.	.	O	O

Continue	Continue	NNP	B-NP	O
ASA/Plavix	ASA/Plavix	NNP	I-NP	O
at	at	IN	B-PP	O
current	current	JJ	B-NP	O
doses	dose	NNS	I-NP	O
x	x	SYM	B-NP	O
1	1	CD	B-NP	O
year	year	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

PULM	PULM	NN	B-NP	O
:	:	:	O	O
likely	likely	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
related	relate	VBN	B-VP	O
to	to	TO	B-PP	O
cardiac	cardiac	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
PE	PE	NN	B-NP	O
per	per	IN	B-PP	O
out-pt	out-pt	JJ	B-NP	O
scan	scan	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
in	in	IN	B-PP	O
setting	setting	NN	B-NP	O
of	of	IN	B-PP	O
venous	venous	JJ	B-NP	O
stasis	stasis	NN	I-NP	O
and	and	CC	O	O
likely	likely	JJ	B-NP	O
peripheral	peripheral	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Treat	Treat	NN	B-NP	O
with	with	IN	B-PP	O
keflex	keflex	NN	B-NP	B-protein
x	x	SYM	O	I-protein
2	2	CD	B-NP	I-protein
weeks	week	NNS	I-NP	I-protein
and	and	CC	O	O
continue	continue	VB	B-VP	O
longer	longer	RBR	B-ADVP	O
if	if	IN	B-SBAR	O
legs	leg	NNS	B-NP	O
still	still	RB	B-ADJP	O
erythematous	erythematous	JJ	I-ADJP	O
.	.	.	O	O

ABX	ABX	NNP	B-NP	O
started	start	VBD	B-VP	O
1/10	1/10	CD	B-NP	O
,	,	,	O	O
stop	stop	VB	B-VP	O
6/17	6/17	CD	B-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
cardiac	cardiac	JJ	B-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Started	Start	VBN	B-NP	O
low	low	JJ	I-NP	O
dose	dose	NN	I-NP	O
potassium	potassium	NN	I-NP	O
10	10	CD	I-NP	O
mEq	mEq	NN	I-NP	O
daily	daily	RB	B-ADVP	O
as	as	IN	B-PP	O
increased	increase	VBN	B-NP	O
lasix	lasix	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	O	O
have	have	VBP	B-VP	O
patient	patient	NN	B-NP	O
check	check	NN	I-NP	O
lytes	lyte	NNS	I-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

FULL	FULL	NN	B-NP	O
CODE	CODE	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
You	You	PRP	B-NP	B-protein
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
have	have	VBP	B-VP	O
new	new	JJ	B-NP	O
stents	stent	NNS	I-NP	O
to	to	TO	B-VP	O
keep	keep	VB	I-VP	O
blood	blood	NN	B-NP	O
flowing	flowing	NN	I-NP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
heart	heart	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	O
MUST	MUST	RB	B-ADVP	O
continue	continue	VBP	B-VP	O
your	your	PRP$	B-NP	O
aspirin	aspirin	NN	I-NP	O
and	and	CC	I-NP	O
plavix	plavix	NN	I-NP	O
.	.	.	O	O

Do	Do	VBP	O	O
NOT	NOT	NN	B-NP	B-protein
discontinue	discontinue	VB	B-VP	O
these	these	DT	B-NP	O
medications	medication	NNS	I-NP	O
without	without	IN	B-PP	O
speaking	speak	VBG	B-VP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
increased	increase	VBN	I-VP	O
your	your	PRP$	B-NP	O
lasix	lasix	NN	I-NP	O
and	and	CC	O	O
your	your	PRP$	B-NP	O
atenolol	atenolol	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
are	be	VBP	B-VP	O
on	on	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
for	for	IN	B-PP	O
cellulitis	cellulitis	NN	B-NP	O
-LRB-	-LRB-	HYPH	O	O
a	a	DT	B-NP	O
skin	skin	NN	I-NP	B-protein
infection	infection	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Continue	Continue	VB	B-VP	O
your	your	PRP$	B-NP	O
toe	toe	NN	I-NP	O
cream	cream	NN	I-NP	O
.	.	.	O	O

Come	Come	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ER	ER	NN	I-NP	B-protein
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
any	any	DT	B-NP	O
trouble	trouble	NN	I-NP	O
breathing	breathing	NN	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
leg	leg	NN	B-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
concerning	concern	VBG	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Satisfactory	Satisfactory	JJ	B-ADJP	O
TO	TO	TO	B-VP	O
DO/PLAN	DO/PLAN	NN	I-VP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Follow	Follow	JJ	B-NP	O
lytes	lyte	NNS	I-NP	O
,	,	,	O	O
LFTs	LFT	NNS	B-NP	B-protein
on	on	IN	B-PP	O
meds	med	NNS	B-NP	O
2	2	CD	B-NP	O
.	.	.	O	O

Follow	Follow	JJ	B-NP	O
LE	LE	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
to	to	TO	B-PP	O
resolution	resolution	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

ECHO	ECHO	NN	B-NP	B-protein
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	B-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Encourage	Encourage	NN	B-NP	O
weight	weight	NN	I-NP	O
reduction	reduction	NN	I-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
MUMBY	MUMBY	NNP	B-NP	O
,	,	,	O	O
FRANKLYN	FRANKLYN	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IS852	IS852	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
6/17/06	6/17/06	CD	I-NP	O
@	@	HYPH	B-NP	O
12	12	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

